Journal profile · Biochemistry & Molecular Biology
Molecular vision
ISSN 1090-0535 · UNITED STATES · Irregular · Founded 1995
Molecular vision: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.67; diamond open access (no APC); no APC; median 301 days to acceptance (10 articles, last 24 months); community-reported acceptance: about 50%; 45 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Molecular vision is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Retinal Development and Disorders, Retinal Diseases and Treatments and Glaucoma and retinal disorders, together about 37.5% of its articles. Its main subfields are Molecular Biology and Ophthalmology. (generated from OpenAlex topic counts and CAS ranking data)
Molecular Vision is a peer-reviewed journal dedicated to the dissemination of research results in molecular biology, cell biology, and the genetics of the visual system (ocular and cortical).
From the journal's Aims & Scope
Research area (LetPub): Biochemistry & Molecular Biology
Editorial board by country: 4 in mainland China (about 3%); most named United States 120, Mainland China 4, France 3, Australia 3, United Kingdom 2 (148 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Retinal Development and DisordersBiochemistry, Genetics and Molecular Biology15.6%
- Retinal Diseases and TreatmentsMedicine13.8%
- Glaucoma and retinal disordersMedicine8.1%
- Ocular Disorders and TreatmentsBiochemistry, Genetics and Molecular Biology6.9%
- Retinal and Macular SurgeryMedicine6.3%
- Ocular Diseases and Behçet’s SyndromeMedicine5%
- Connexins and lens biologyBiochemistry, Genetics and Molecular Biology5%
- Corneal surgery and disordersMedicine4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Ophthalmology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Ophthalmology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Ophthalmology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedCASCurrent ContentsPublisher website
Other: Index Medicus, Biological Abstracts
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.67LetPub ·
- CiteScore 2026-06
- 2.2LetPub ·
- SJR 2026-06
- 0.5LetPub ·
- SNIP 2026-06
- 0.55LetPub ·
- h-index
- 83LetPub ·
- h-index
- 4OpenAlex ·
- i10-index
- 3OpenAlex ·
- 2-year mean citedness
- 0.53OpenAlex ·
- Self-citation rate
- 5.6%LetPub ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 25LetPub ·
Articles by year OpenAlex count · 80 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 19 | 19 | 2 |
| 2025 | 45 | 45 | 14 |
| 2024 | 10 | 10 | 23 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
301 daysMedian, submission to acceptance · P25–P75 251 days – 422 days
- Acceptance to online
- median 2 days (9 articles)
- Submission to online
- median 317 days
- Sample
- 10 articles with submission and acceptance dates (77 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC-ND | |
| LetPub | No APC | No | — | |
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Not considered
- Insufficient data; small sample groups; underpowered studies; simple reports of sequence data; identification of polymorphisms
Article types accepted3
- research articleResearch Article: A detailed description of original, unpublished work covering a positive or negative result of significance.Length not stated
- reviewReview: The Editors solicit suggestions for comprehensive articles reviewing the current status of a particular field or topic.Length not stated
- technical briefTechnical Brief: This is a short account detailing a novel method or unique use of current technology that of itself, regardless of the experimental question st…Length not stated
Policy excerpts from the journal's websiteAuthorship, License & copyright, Open access, Peer review
- Authorship
No publication charges Model summary
Molecular Vision has no publication charges (even for color images)
Source ↗Publisher website ·- License & copyright
Permission required for previously published material Model summary
If any figures, graphs, tables, or data previously published are used, written permission of the publisher of the previous work must be presented.
Source ↗Publisher website ·- Open access
Free access to articles and services Model summary
Access to the journal (articles and services) is free of charge.
Source ↗Publisher website ·- Peer review
No simple sequence data or polymorphism reports Model summary
Molecular Vision does not publish simple reports of sequence data or identification of polymorphisms.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Irregular
- Founded
- 1995
- ISSN
- 1090-0535
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Molecular vision
What CAS zone is Molecular vision in?
In the 2025 upgraded edition of the CAS Journal Ranking, Molecular vision is in Zone 4 of Medicine, and in Zone 4 of the minor category Biochemistry & Molecular Biology / Ophthalmology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Molecular vision?
The latest impact factor listed by LetPub is 1.67; CiteScore 2.2, h-index 4.
How long does peer review take at Molecular vision?
Based on the dates recorded on 10 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 301 days (interquartile range 251–422 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 50%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Molecular vision based?
Of the 148 board members whose country the journal's board page names, 4 (about 3%) are in mainland China; the countries named most often are United States (120), Mainland China (4) and France (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Molecular vision?
According to LetPub and DOAJ records, Molecular vision is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, PubMed, CAS and Current Contents; that list has not been checked against each database.
Is Molecular vision open access, and what is the APC?
Molecular vision is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .